{
  "ptid_time": "141_S_4711_2012-05-12",
  "img_path": "/data/qiuhui/data/adni/images/141_S_4711/2012-05-12/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 46,841 mm³, 66.9% above the reference mean. With a Z-score of 1.53 (93.7th percentile), this represents moderate enlargement; hippocampal volume measures 7,856 mm³, 10.4% above the reference mean. With a Z-score of 0.96 (83.0th percentile), this represents normal volume ; whole brain volume measures 1,197,390 mm³, 22.9% above the reference mean. With a Z-score of 2.88 (99.8th percentile), this represents significant enlargement; entorhinal cortex volume measures 3,985 mm³, 8.5% above the reference mean. With a Z-score of 0.52 (69.9th percentile), this represents normal volume ; fusiform gyrus volume measures 22,431 mm³, 31.8% above the reference mean. With a Z-score of 2.90 (99.8th percentile), this represents significant enlargement; middle temporal gyrus volume measures 24,661 mm³, 28.6% above the reference mean. With a Z-score of 2.49 (99.4th percentile), this represents significant enlargement. ",
  "text_data": "Age is 74.9 years. Gender is Female. Education: 17 years. Handedness: Left. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 27.0. MoCA: 22.0. Logical Memory: 5.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.02 SUVR (normal ); Amyloid beta: 1417.00 pg/mL (mild elevated); Total tau: 208.80 pg/mL (normal ); Phosphorylated tau: 18.45 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The brain volume data shows significant enlargement in whole brain, fusiform gyrus, and middle temporal gyrus, with normal hippocampal and entorhinal cortex volumes. Ventricular enlargement is moderate, but not severe. Clinically, the patient has a normal MMSE (27/30) but borderline MoCA (22/30), mild Aβ elevation, and normal tau markers. APOE4-negative status reduces Alzheimer’s risk.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting imaging findings—some atrophy but also enlarged regions—and mild Aβ elevation without tau pathology).",
  "timestamp": "2025-07-26T17:05:05.075928"
}